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Human subjects
Blood samples for DNA extraction were collected from familial EGFR-mutant lung cancer cases and unaffected control individuals after informed consent was obtained. The protocol was approved by the Institutional Review Board at Tohoku University Graduate School of Medicine (Sendai, Japan).
Exome capture and sequencing
Exome capture was performed with the SureSelect Human All Exon V4 (Agilent Technologies, Santa Clara, CA). Exome capture libraries were sequenced by HiSeq 2000 (Illumina, San Diego, CA) to obtain at least 83 million paired-end (2 × 101 base pairs) reads per each sample. A targeted mean coverage depth of 106-198 × with 74-91% of bases covered at ≥50 × was achieved for 51 Mb exome libraries (Table S1 ).
Exome data processing and analysis
Paired-end reads were mapped to the reference human genome (UCSC hg19 from the Genome Analysis Toolkit 1.5 package) using BWA software version 0.5.9-r26. (1) The BWA mapped sequencing reads were processed by Picard (version 1.79; http://picard.sourceforge.net/) to label the PCR duplicates. Then, the allelic variants were detected using the Genome Analysis Toolkit version 1.6-13. (2) Annotations of single nucleotide variants and insertions/deletions were made using ANNOVAR (released on 23 October 2012) against NCBI's Reference Sequence (RefSeq) version 57 and dbSNP version 135 databases. (3) (4) (5) The effect of an exonic variant on the gene function was predicted using Polymorphism Phenotyping version 2 (PolyPhen-2) and Combined Annotation Dependent Depletion (CADD) version 1.2. (6, 7) The allele frequency of an identified variant was determined in 1,070 healthy Japanese individuals and 6,503 American individuals 
Three-dimensional modeling
The molecular structures of human wild-type and p.Asn375Lys-mutant MET were visualized and analyzed using the structural data of HGF β-chain and MET complex (Protein Data Bank accession 1SHY) with the UCSF Chimera software version 1.10.1. (9, 10) In this software, hydrogen-bonds were detected using a set of detailed distance and angle criteria from a published small-molecule crystal survey. (11) 
Cell culture
Human non-small cell lung cancer NCI-H1299 (hereafter H1299) cells were obtained from the American Type Culture Collection (Manassas, VA). The monkey kidney fibroblast COS-7 cells were obtained from the Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University (Sendai, Japan). Cells were maintained at 37°C in 5% CO2 with complete media-i.e., RPMI-1640 (for H1299, Sigma-Aldrich, St. Louis, MO) and Dulbecco's modified Eagle's medium (DMEM, for COS-7, Sigma-Aldrich) supplemented with 10% fetal bovine serum (Nichirei, Tokyo, Japan), 100 U/ml penicillin (Life Technologies, Carlsbad, CA), and 100 μg/ml streptomycin (Life Technologies). Where indicated, the serum concentration of the complete RPMI-1640 was reduced to 1% for low-serum media. 
Production and purification of fusion proteins
The coding sequence of human MET ectodomain (amino acid residues 1-923 in NP_000236. 2) was ligated in-frame with that of human immunoglobulin G1 Fc region (amino acid residues in AFF59210) at the NH2-terminus, in order to construct the coding sequence for wild-type MET-Fc fusion protein with a spacer sequence Pro-Gly-Val-Pro-Gly. Using the constructed coding sequence as a template, the coding sequence for p.Asn375Lys-mutant MET-Fc fusion protein was also generated using the PrimeSTAR Mutagenesis Basal Kit (Takara Bio, Kusatsu, Japan) and the following primers; 5'-TCTTCAAGAAGATCGTCAACAAAAAC-3' and 5' CGATCTTCTTGAAGAAGTCGTTGACA-3'. The mutated sequence was validated by Sanger sequencing with the following forward and reverse primers; 
Enzyme-linked immunosorbent assay (ELISA)
The binding affinity of human HGF protein to wild-type or p.Asn375Lys-mutant MET-Fc fusion protein was quantitatively analyzed using a Human HGF DuoSet ELISA kit (R&D Systems, Minneapolis, MN). Briefly, each of the MET-Fc fusion proteins was immobilized on a 96-well microplate at 1 μg/ml by incubation for 24 hours at room temperature. Each well was washed with 
Coprecipitation assay
Each of the MET-Fc fusion proteins (2 μg) was incubated with Protein G-Sepharose 4B (100 μl of a 50% slurry; Sigma-Aldrich) in HNTG buffer (20 mM HEPES buffer [pH 7.5], 150 mM NaCl, 0.1% Triton X-100, and 10% glycerol) with rocking for 1 hour at room temperature. Precipitations were washed three times in the buffer and then resuspended in 500 μl recombinant human HGF protein (80 ng/ml, HumanZyme) in the buffer. After 24-hour incubation at 4°C, complexes were recovered by centrifugation, washed three times with the buffer and heated at 95°C for 5 minutes in Laemmli sample buffer (Bio-Rad Laboratories, Hercules, CA). The eluate was separated by electrophoresis on a 10% SDS-polyacrylamide gel and transferred to a polyvinylidene difluoride (PVDF) membrane (EMD Millipore, Darmstadt, Germany) for immunoblot analysis with antibodies against human MET (clone EP1454Y, Abcam, Cambridge, United Kingdom) and human HGF (catalogue no. AF-294-NA, R&D Systems). hexadimethrine bromide (Sigma-Aldrich). Stable transductants were selected and isolated in complete RPMI-1640 media containing 500 μg/ml G418 (Thermo Fisher Scientific).
Proliferation assay
Cellular proliferation was examined as described previously. (12) Briefly, in a 96-well cultured plate, transduced H1299 cells were seeded at 3 × 10 3 cells per well. After 24-hour culture in complete RPMI-1640 media, the cells were then cultured without serum for another 24 hours. The serum-starved cells were further cultured in low-serum RPMI-1640 media supplemented with 5 ng/ml recombinant human HGF protein (HumanZyme) for an additional 2 or 4 days. The number of viable cells was determined by a colorimetric method using MTS (3-4,5-dimethylthiazol-2-yl-5-3-carboxymethoxyphenyl-2-4-sulfophenyl-2H-tetrazolium, inner salt) (CellTiter 96, Promega, Madison, WI) according to the manufacturer's instructions. 
Colony formation assay
The clonogenic potential was examined as described previously. (13) In brief, transduced H1299 cells were seeded into 60-mm culture dishes at 1 × 10 3 cells per dish. After 24-hour culture in complete RPMI-1640 media, the cells were then cultured without serum for another 24 hours. The serum-starved cells were further cultured in low-serum RPMI-1640 media supplemented with 5 ng/ml recombinant human HGF protein (HumanZyme) for an additional 14 days. The cultures were fixed and stained with crystal violet staining solution in methanol (Kanto Chemical, Tokyo, Japan) for 20 minutes at room temperature. After washing the dishes with water, the colonies were macroscopically counted. The data were reported as colony numbers per dish.
Wound healing assay
Transduced H1299 cells were seeded at 3 × 10 5 cells per well of a 6-well cultured plate in triplicate.
After 24-hour culture in complete RPMI-1640 media, the cells were then cultured without serum for another 24 hours. The serum-starved cell monolayer was gently scratched through the central axis of the well with a 1-ml pipette tip. To remove the cellular debris, the monolayer was washed with PBS. The cells were further cultured in low-serum RPMI-1640 media supplemented with 5 ng/ml recombinant human HGF protein (HumanZyme) for an additional 48 hours. Bright-field and phase contrast microphotograph images were collected and analyzed using a BX53 microscope (OLYMPUS, Tokyo, Japan) and LuminaVision software (MITANI, Tokyo, Japan) at the start and end of the culture. The percentage of the closed wound area at the end was determined and compared with the open wound area at the start.
Cell extracts and immunoblotting
Transduced H1299 cells were seeded at 3 × 10 5 cells per well of a 6-well cultured plate. After 24-hour culture in complete RPMI-1640 media, the cells were then cultured without serum for 
Animal studies
BALB/c nu/nu mice (6-10 weeks old, female) were purchased from Charles River Japan (Yokohama, Japan) and housed under specific-pathogen-free conditions. Transduced H1299 lung cancer cells (2.5 × 10 6 ) were injected subcutaneously in the right flank of the mice on day 0. On and after day 26, the size of each tumor was assessed two or three times weekly and the volume was recorded in mm 3 (length by width 2 × 0.5) as previously described. (14) On day 54, the tumors were carefully dissected out from the surrounding normal tissue for taking macroscopic pictures -9 - and weighed.
Statistical analysis
Two data sets were compared by Student's unpaired two-tailed t-test. For multiple comparisons, post hoc analysis was performed by Tukey's honestly significant difference test. P values less than 0.05 were considered statistically significant. Error bars in the graphical data represent the means ± standard error.
Figure S1
Tode et al Figure S1 . Chest CT and brain MRI of subject 1 (an 80-year-old woman). Chest CT; a rounded, sharply defined solitary nodule was seen in the right inferior lobe. Brain MRI; irregularly shaped nodules were seen in the brainstem.
Chest CT
Brain MRI Table S1 Tode et al * Abbreviations: no, number; NA, not applicable for a non-participant in this study; w/o, without. † The human genome (UCSC hg19 from the Genome Analysis Toolkit 1.5 package) was used as reference for the mapping. ‡ Reads were considered to be "on target" if at least 1 base pair was shared by the target regions. (14) 29 (11) 33 (13) Frameshift deletion 27 (8) 27 (8) 28 (7) 28 (7) 23 (6) * Abbreviations: chr, chromosome; AA, amino acid; hom, homozygosity; het, heterozygosity; MAF, minor allele frequency (< 1/2140); NA, not available. † Genetic positions on the chromosomes were defined in NC_000001.10 (chr 1), NC_000002.11 (chr 2), NC_000003.11 (chr 3), NC_000004.11 (chr 4), and NC_000005.9 (chr 5). ‡ Local allele frequency (Freq. JPN) was determined by using the database of the Tohoku University Tohoku Medical Megabank Organization (n = 1070 Japanese individuals) with reference to that of the NHLBI GO Exome Sequencing Project (Freq. ESP).
Table S3
Tode et al * Abbreviations: chr, chromosome; AA, amino acid; hom, homozygosity; het, heterozygosity; MAF, minor allele frequency (< 1/2140); NA, not available. † Genetic positions on the chromosomes were defined in NC_000009.11 (chr 9), NC_000010.10 (chr 10), NC_000011.10 (chr 11), NC_000012.11 (chr 12), and NC_000015.9 (chr 15). ‡ Local allele frequency (Freq. JPN) was determined by using the database of the Tohoku University Tohoku Medical Megabank Organization (n = 1070 Japanese individuals) with reference to that of the NHLBI GO Exome Sequencing Project (Freq. ESP). * The published data (Nature 2014; 511: 543-50) were obtained from the cBio Cancer Genomics Portal (http://cbioportal.org) on February 17, 2017. † EGFR mutations include Del19 (n, 10), L858R (n, 8), L861Q (n, 3), G719A (n, 1), K754I (n, 1), S768I (n, 1), and H773dup (n, 1). ‡ The mRNA expression levels of MET were determined by using the RNA sequence data and the RSEM software, and indicated as Z-score, the number of standard deviations away from the mean of expression in the reference population.
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